Insiders Trades

★ Sign in to follow

PB

Peter Behner

US·SEC (Form 4)

MiNK Therapeutics, Inc.

Cumul. flow

Total declarations

16

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 02 Jun 2026 for MiNK Therapeutics, Inc., €14k.

Insider track record

Disclosed buys

0

Disclosed sells

0

Signal history

Peter Behner: trading record in brief

Peter Behner appears in our data through filings on MiNK Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 16 filings, for trades running from 15 September 2022 to 1 June 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 2 June 2026, reports a share grant of €14k in MiNK Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Peter Behner

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

MiNK Therapeutics, Inc. (US)

Declarations16 total

◆

DirectorExecutives1 Jun 2026MiNK Therapeutics, Inc.

16,255 USD12SEC

1,313 shares@ US$12.380.026% mcap5.7% of flowCommon StockSEC:0001193125-26-253466:1

◆

DirectorExecutives2 Mar 2026MiNK Therapeutics, Inc.

16,252 USD12SEC

1,491 shares@ US$10.905.6% of flowCommon StockSEC:0001193125-26-253466:0

◆

DirectorExecutives1 Dec 2025MiNK Therapeutics, Inc.

16,258 USD12SEC

1,466 shares@ US$11.095.7% of flowCommon StockSEC:0001193125-25-306680:0

◆

DirectorExecutives2 Sept 2025MiNK Therapeutics, Inc.

16,258 USD12SEC

1,173 shares@ US$13.865.7% of flowCommon StockSEC:0000950170-25-112882:0

◆

DirectorExecutives2 Jun 2025MiNK Therapeutics, Inc.

16,254 USD12SEC

2,267 shares@ US$7.175.8% of flowCommon StockSEC:0000950170-25-081612:0

◆

DirectorExecutives3 Mar 2025MiNK Therapeutics, Inc.

16,253 USD12SEC

1,849 shares@ US$8.796.4% of flowCommon StockSEC:0000950170-25-033528:0

◆

DirectorExecutives1 Dec 2024MiNK Therapeutics, Inc.

15,321 USD12SEC

20,987 shares@ US$0.735.9% of flowCommon StockSEC:0000950170-24-132520:0

◆

DirectorExecutives3 Sept 2024MiNK Therapeutics, Inc.

15,377 USD12SEC

18,753 shares@ US$0.825.7% of flowCommon StockSEC:0000950170-24-103749:0

◆

DirectorExecutives3 Jun 2024MiNK Therapeutics, Inc.

15,299 USD12SEC

15,454 shares@ US$0.995.7% of flowCommon StockSEC:0000950170-24-069216:0

◆

DirectorExecutives1 Mar 2024MiNK Therapeutics, Inc.

15,376 USD12SEC

16,185 shares@ US$0.955.8% of flowCommon StockSEC:0000950170-24-026423:0

◆

DirectorExecutives1 Dec 2023MiNK Therapeutics, Inc.

15,375 USD12SEC

14,784 shares@ US$1.045.8% of flowCommon StockSEC:0000950170-23-068311:0

◆

DirectorExecutives1 Sept 2023MiNK Therapeutics, Inc.

15,375 USD12SEC

10,531 shares@ US$1.465.8% of flowCommon StockSEC:0000950170-23-046777:0

◆

DirectorExecutives1 Jun 2023MiNK Therapeutics, Inc.

15,375 USD12SEC

8,736 shares@ US$1.765.8% of flowCommon StockSEC:0000899243-23-014412:0

◆

DirectorExecutives1 Mar 2023MiNK Therapeutics, Inc.

15,376 USD12SEC

7,357 shares@ US$2.095.9% of flowCommon StockSEC:0000899243-23-006912:0

◆

DirectorExecutives1 Dec 2022MiNK Therapeutics, Inc.

15,376 USD12SEC

5,891 shares@ US$2.616.0% of flowCommon StockSEC:0000899243-22-037646:0

◆

DirectorExecutives15 Sept 2022MiNK Therapeutics, Inc.

30,751 USD12SEC

11,737 shares@ US$2.6212.6% of flowCommon StockSEC:0000899243-22-031530:0

16 of 16 declarations